Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fish oil-Region Skane refers to a specific omega-3 fatty acid supplement preparation used in clinical research conducted by Region Skane (Skåne University Hospital, Sweden). The supplement contains the long-chain polyunsaturated fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). It was investigated in the clinical trial NCT03048981 to evaluate its dose-dependent effects on platelet function and coagulation in healthy volunteers. The study aimed to provide evidence for clinical guidelines regarding the preoperative discontinuation of fish oil, as these fatty acids are known to inhibit platelet aggregation and potentially increase bleeding risk by competing with arachidonic acid in the cyclooxygenase pathway, thereby reducing the production of pro-aggregatory thromboxanes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fish oil-Region Skane.